Moreover, there were significantly higher concentrations of p-mTOR in the kidneys of the CIS-treated Gal-3 wild-type mice than in the CIS-treated Gal-3 KO mice, with statistical significance (p < 0.01) (Figure 7B). The gene discussed is MTOR; the disease is in situ carcinoma.